InspireMD, Inc. NSPR
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -4.64% | -16.39% | 7.45% | 3.37% | -17.78% |
| Total Depreciation and Amortization | 6.04% | 4.20% | 11.72% | 19.63% | 9.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.75% | 2.96% | -39.45% | 4.38% | 23.22% |
| Change in Net Operating Assets | 194.41% | -1,418.75% | -75.38% | -73.81% | 329.81% |
| Cash from Operations | 11.69% | -32.02% | -8.25% | -3.60% | 5.22% |
| Capital Expenditure | -70.10% | 51.26% | -20.97% | 42.88% | -60.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.07% | 133.47% | -668.81% | 33.35% | 186.17% |
| Cash from Investing | -0.85% | 132.74% | -697.74% | 41.88% | 212.69% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | 2,522.93% | 304.73% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 200.70% | -- | 100.00% |
| Cash from Financing | -- | -- | -100.00% | 2,376.65% | 322.33% |
| Foreign Exchange rate Adjustments | 252.63% | -218.75% | -68.00% | -- | -100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 56.29% | 104.45% | -204.95% | 6,037.53% | 86.62% |